Search Results - "Rahman, Muhammad Aadil"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Spleen and Symptom Responses of JAK Inhibitors in Myelofibrosis; A Systematic Review of Phase 2 and 3 Trials by Sharif, Muhammad Ans, Faisal, Muhammad Salman, Samhouri, Yazan, Hashim, Laila, Yasir, Muhammad, Anwar, Muhammad Yasir, Khan, Ali Younas, Shahzad, Moazzam, Javaid, Anum, Rahman, Muhammad Aadil, Anwer, Faiz, Fazal, Salman

    Published in Blood (05-11-2020)
    “…Background: The JAK-STAT pathway is a vital signaling pathway for various cytokines and growth factors. An abnormal upregulation of this pathway is seen in…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Dartumumab in Pretreated AL Amyloidosis: A Systematic Review by Ansar, Iqraa, Neupane, Karun, Ehsan, Hamid, Anwar, Muhammad Yasir, Imtiaz, Hassaan, Khan, Ali Younas, Javaid, Anum, Rahman, Muhammad Aadil, Afzal, Hafiz Muhammad Haroon, Butt, Kanza Noor, Faisal, Muhammad Salman, Wahab, Ahsan, Ansar, Sadia, Anwer, Faiz

    Published in Blood (05-11-2020)
    “…Background: Amyloidosis is characterized by the deposition of misfolded lambda or kappa light chain (AL) proteins in tissue. It commonly affects the heart,…”
    Get full text
    Journal Article
  4. 4

    Efficacy and Tolerability of Daratumumab in Heavily Pretreated AL Amyloidosis: A Systematic Review by Rahman, Muhammad Aadil, Khan, Ali Younas, Ijaz, Awais, Tariq, Muhammad Junaid, Usman, Muhammad, Khalil, Muhammad Jahanzeb, Fraz, Muhammad Asad, Jamil, Faiza, Rafae, Abdul, Malik, Mustafa Nadeem, Selene, Insija Ilyas, Jose, Jemin Aby, Safdar, Ahmad, McBride, Ali, Anwer, Faiz

    Published in Blood (29-11-2018)
    “…Introduction Light chain (AL) amyloidosis is a low burden plasma cell disorder, characterized by deposition of misfolded lambda or kappa light chains. Kidney…”
    Get full text
    Journal Article
  5. 5